Sotera Health Company SHC

Full chart Compare
Set alert

Price alert · SHC

All alert types
15.98 USD -1.76 (-9.95%)

Nov 3, 2026, 3:57 PM EST

15.90 Day range 17.28
13.09 52-week range 19.85
YTD
-9.44%
1 year
-3.82%

Analyst view

Consensus: buy

Buy
Price target (mean) 22.61 +41.5% upside
Target (low)
17.00
Target (mean)
22.61
Target (high)
25.00
Ratings (0m) 10 8 buy · 1 hold · 1 sell
  • Strong buy3
  • Buy5
  • Hold1
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 10
  • 1 month ago 10
  • 2 months ago 10

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SHC analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.268640.26 – 0.270.26+3.3%319.88M+2.8%10
Next quarter0.275570.27 – 0.280.26+6.0%325.60M+7.3%10
Current year0.983830.978 – 0.990.86+14.4%1.25B+7.2%10
Next year1.071.03 – 1.130.98383+9.3%1.32B+5.9%10

Upgrades and downgrades

The latest rating changes

SHC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2026JP MorganDowngradeNeutralUnderweight
Aug 7, 2026CitigroupMaintainedBuyBuy
Aug 7, 2026BarclaysMaintainedOverweightOverweight
Aug 7, 2026Piper SandlerReiteratedOverweightOverweight
Aug 7, 2026JP MorganMaintainedNeutralNeutral
Jun 24, 2026BarclaysMaintainedOverweightOverweight
Jun 5, 2026Goldman SachsInitiatedBuyBuy
May 6, 2026Piper SandlerReiteratedOverweightOverweight
Apr 14, 2026BarclaysMaintainedOverweightOverweight
Feb 24, 2026CitigroupMaintainedBuyBuy
Jan 9, 2026Piper SandlerUpgradeNeutralOverweight
Dec 18, 2025William BlairInitiated—Outperform
Nov 13, 2025BMO CapitalInitiated—Outperform
Nov 5, 2025JP MorganMaintainedNeutralNeutral
Nov 5, 2025BarclaysMaintainedOverweightOverweight
Nov 5, 2025Piper SandlerMaintainedNeutralNeutral
Oct 2, 2025BarclaysMaintainedOverweightOverweight
Jun 24, 2025BarclaysMaintainedOverweightOverweight
May 5, 2025Goldman SachsUpgradeNeutralBuy
Apr 23, 2025Piper SandlerMaintainedNeutralNeutral
Apr 10, 2025BarclaysMaintainedOverweightOverweight
Feb 28, 2025BarclaysMaintainedOverweightOverweight
Feb 18, 2025BarclaysMaintainedOverweightOverweight
Nov 21, 2024RBC CapitalReiteratedOutperformOutperform
Nov 6, 2024CitigroupMaintainedBuyBuy
Aug 6, 2024BarclaysMaintainedOverweightOverweight
Aug 6, 2024RBC CapitalReiteratedOutperformOutperform
May 21, 2024Piper SandlerInitiated—Neutral
Apr 10, 2024BarclaysMaintainedOverweightOverweight
Apr 3, 2024CitigroupUpgradeNeutralBuy